SummaryObjectiveAssess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler®+tiotropium (TIO) HandiHaler® vs. placebo (PBO)+TIO in patients with chronic obstructive pulmonary disease (COPD) eligible for inhaled corticosteroids/long-acting β2-agonists (ICS/LABA).MethodsThe cost-effectiveness analysis was based on the 12-week, randomised, double-blind CLIMB trial. The study included 659 patients with pre-bronchodilator forced expiratory volume in 1 s ≤ 50% and ≥1 exacerbation requiring systemic glucocorticosteroids or antibiotics the preceding year. Patients received BUD/FORM 320/9 μg bid + TIO 18 μg qd or PBO bid + TIO 18 μg qd. Effectiveness was defined as the number of severe exacerbations (hospitalisation/emergency room v...
SummaryObjectiveTo evaluate the cost-utility of adding tiotropium to usual care versus usual care al...
Introduction/Aim: Results from the recent one-year FLAME study demonstrated superior efficacy of IND...
Background: This study assessed the cost-effectiveness of indacaterol/glycopyrronium (IND/GLY) versu...
Objective: Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler®+tiotropium ...
SummaryObjectiveAssess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler®+tiotro...
Objective: To compare the healthcare costs and effects of budesonide/formoterol in,a single inhaler ...
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinati...
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinati...
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinati...
Oskar Eklund,1 Faraz Afzal,2 Fredrik Borgström,1 Jason Flavin,3 Andrew Ternouth,4 Maria Eugenia...
Hoogendoorn M, Al MJ, Beeh K-M, et al. Cost-effectiveness of tiotropium versus salmeterol: the POET-...
A head-to-head study demonstrated the superiority of once-daily umeclidinium bromide/vilanterol (UME...
Abstract Background A head-to-head study demonstrated the superiority of once-daily umeclidinium bro...
PURPOSE: The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed in...
Background: The aim of this study was to estimate the cost-effectiveness of tiotropium versus salmet...
SummaryObjectiveTo evaluate the cost-utility of adding tiotropium to usual care versus usual care al...
Introduction/Aim: Results from the recent one-year FLAME study demonstrated superior efficacy of IND...
Background: This study assessed the cost-effectiveness of indacaterol/glycopyrronium (IND/GLY) versu...
Objective: Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler®+tiotropium ...
SummaryObjectiveAssess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler®+tiotro...
Objective: To compare the healthcare costs and effects of budesonide/formoterol in,a single inhaler ...
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinati...
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinati...
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment with combinati...
Oskar Eklund,1 Faraz Afzal,2 Fredrik Borgström,1 Jason Flavin,3 Andrew Ternouth,4 Maria Eugenia...
Hoogendoorn M, Al MJ, Beeh K-M, et al. Cost-effectiveness of tiotropium versus salmeterol: the POET-...
A head-to-head study demonstrated the superiority of once-daily umeclidinium bromide/vilanterol (UME...
Abstract Background A head-to-head study demonstrated the superiority of once-daily umeclidinium bro...
PURPOSE: The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed in...
Background: The aim of this study was to estimate the cost-effectiveness of tiotropium versus salmet...
SummaryObjectiveTo evaluate the cost-utility of adding tiotropium to usual care versus usual care al...
Introduction/Aim: Results from the recent one-year FLAME study demonstrated superior efficacy of IND...
Background: This study assessed the cost-effectiveness of indacaterol/glycopyrronium (IND/GLY) versu...